Latest news
Does Moderna’s Wider 2026 Loss Amid Pipeline Spend Change The Bull Case For MRNA? - simplywall.stsimplywall.st · Mon, 03 Aug 2026 03:46:59 GMTBeyondSpring Inc. (BYSI) Q1 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss Amid Pipeline Progress - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 13:44:31 GMT